Citations for
1FES, JAK3, PLD2
A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells.
Ye Q, Kantonen S, Henkels KM, Gomez-Cambronero J.
J Biol Chem 288(14):9881-91. doi: 10.1074/jbc.M113.450593. Epub 2013 Feb 12. 2013
2FES, PLD1, PLD2
Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.
Di Fulvio M, Frondorf K, Henkels KM, Grunwald WC Jr, Cool D, Gomez-Cambronero J.
J Biol Chem 287(1):393-407. doi: 10.1074/jbc.M111.259465. Epub 2011 Nov 17. 2012
3FES
Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.
Zhang S, Chitu V, Stanley ER, Elliott BE, Greer PA.
Cancer Res 71(4):1465-73. doi: 10.1158/0008-5472.CAN-10-3757. Epub 2010 Dec 15. 2011
4FES, KIT, KITLG
FES kinase participates in KIT-ligand induced chemotaxis.
Voisset E, Lopez S, Chaix A, Vita M, George C, Dubreuil P, De Sepulveda P.
Biochem Biophys Res Commun 393(1):174-8. Epub 2010 Feb 1. 2010
5FES
Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.
Smith JA, Samayawardhena LA, Craig AW.
Cell Signal 22(3):427-36. doi: 10.1016/j.cellsig.2009.10.014. Epub . 2010
6FES
Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer.
Shaffer JM, Smithgall TE.
Genes Chromosomes Cancer 48(3):272-84. 2009
7FES
A growth-suppressive function for the c-fes protein-tyrosine kinase in colorectal cancer.
Delfino FJ, Stevenson H, Smithgall TE.
J Biol Chem 281(13):8829-35. Epub 2006 Feb 2. 2006
8TRIM28, FES
The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.
Delfino FJ, Shaffer JM, Smithgall TE.
Biochem J 399(1):141-50. 2006
9FES
NMR assignment of the SH2 domain from the human feline sarcoma oncogene FES.
Scott A, Pantoja-Uceda D, Koshiba S, Inoue M, Kigawa T, Terada T, Shirouzu M, Tanaka A, Sugano S, Yokoyama S, Guntert P.
J Biomol NMR 30(4):463-4. No abstract available. 2004
10FES
Fes mediates the IL-4 activation of insulin receptor substrate-2 and cellular proliferation.
Jiang H, Foltenyi K, Kashiwada M, Donahue L, Vuong B, Hehn B, Rothman P.
J Immunol 166(4):2627-34. 2001
11FES
Molecular genetic analysis of 15q-qter markers in patients with ring 15 and Russel-Silver syndromes. (abstr)
Butler MG, et al.
Cytogenet Cell Genet 67 : 15. 1994
12FES
Confirmation of 15q26.1 as the site of the FES protooncogene by fluorescence in situ hybridization.
Mathew S, et al.
Cytogenet Cell Genet 63 : 33-34. 1993
13FES
Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
Jücker M, Roebroek AJ, Mautner J, Koch K, Eick D, Diehl V, Van de Ven WJ, Tesch H.
Oncogene 7(5):943-52. 1992
14FES
Tetranucleotide repeat polymorphism at the human c-fes/fps proto-oncogene (FES).
Polymeropoulos MH, et al.
Nucleic Acids Res 19 : 4018. 1991
15FES
An insertion deletion polymorphism associated with C-FES.
Bowden DW, et al.
Nucleic Acids Res 19 : 4311. 1991
16FES
Polymorphism at the FES locus detected by PFGE.
Koch K, et al.
Nucleic Acids Res 18 : 5918. 1990
17FES
Characterization of human and mouse c-fes cDNA clones and identification of the 5' end of the gene.
Alcalay M, Antolini F, Van de Ven WJ, Lanfrancone L, Grignani F, Pelicci PG.
Oncogene 5(3):267-75. 1990
18FES
RFLP of the human c-fes proto-oncogene.
Tesch H, et al.
Nucleic Acids Res 16 : 4193. 1988
19FES, MYB
Chromosomal sublocalization of human c-myb and c-fes cellular onc genes.
Harper ME, et al.
Nature 304 : 169-171. 1983
20ABL1, FES
Chromosomal localization of human cellular homologues of two viral oncogenes.
Heisterkamp N, et al.
Nature 299 : 747-749. 1982
21FES, MYB
Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis onc genes.
Dalla-Favera R, et al.
Proc Natl Acad Sci U S A 79 : 4714-4717. 1982